Weighted Average Number of Shares Outstanding, Diluted of Evofem Biosciences, Inc. from 30 Jun 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Evofem Biosciences, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2020 to 31 Dec 2025.
  • Evofem Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 6,421,746,555, a 7927% increase year-over-year.
  • Evofem Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 6,421,746,555, a 7927% increase from 2024.
  • Evofem Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 80,003,309, a 92% decline from 2023.
  • Evofem Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 984,038,574, a 211082% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Evofem Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 6,421,746,555 +6,341,743,246 +7927% 01 Oct 2025 31 Dec 2025 10-K 11 Mar 2026 2025 FY
Q3 2025 119,578,093 +23,118,972 +24% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 115,686,024 -1,498,036,188 -93% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 6,039,898,041 +6,008,703,648 +19262% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 80,003,309 -904,035,265 -92% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2026 2025 FY
Q3 2024 96,459,121 -633,520,365 -87% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 1,613,722,212 +1,612,146,054 +102283% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 31,194,393 +29,922,869 +2353% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 984,038,574 +983,572,607 +211082% 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 729,979,486 +725,537,514 +16334% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 1,576,158 +1,359,130 +626% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 1,271,524 -9,821,338 -89% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 465,967 -8,261,286 -95% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 4,441,972 -5,842,393 -57% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 217,028 -8,127,543 -97% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 11,092,862 +5,636,641 +103% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 8,727,253 01 Oct 2021 31 Dec 2021 10-K 27 Apr 2023 2022 FY
Q3 2021 10,284,365 -70,921,736 -87% 01 Jul 2021 30 Sep 2021 10-Q 06 Jan 2023 2022 Q3
Q2 2021 8,344,571 -49,351,948 -86% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 5,456,221 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q3 2020 81,206,101 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 57,696,519 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2

Evofem Biosciences, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 6,421,746,555 +6,341,743,246 +7927% 01 Jan 2025 31 Dec 2025 10-K 11 Mar 2026 2025 FY
2024 80,003,309 -904,035,265 -92% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2026 2025 FY
2023 984,038,574 +983,572,607 +211082% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 465,967 -8,261,286 -95% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 8,727,253 -58,430,025 -87% 01 Jan 2021 31 Dec 2021 10-K 27 Apr 2023 2022 FY
2020 67,157,278 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.